Skip to main content
Log in

Neurotropic activity of phenylpyrrolidone-2 isomers

  • Pharmacology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Pyrrolidone-2 (P 2) is a cyclic form of gamma-aminobutyric acid (GABA). In experiments on mice and rats the pharmacological activity of three isomers of phenyl derivatives of P 2 was investigated. All the compounds inhibited motor activity, lowered muscle tone and body temperature, potentiated the action of hexobarbital, and possessed anticonvulsive (electrical shock, strychnine, metrazol, thiosemicarbazide, audiogenic convulsions) and narcotic activity. The most active isomer was 4-phenylpyrrolidone-2 (phepyron). Comparison of the pharmacological activity of phenyl derivatives of P 2 and analogous derivatives of GABA showed that the GABA derivatives have no anticonvulsive or narcotic activity and are less toxic. It is suggested that the phenyl derivatives of P 2 are not converted into the analogous GABA derivatives in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature Cited

  1. M. L. Belen'kii, Elements of Quantitative Evaluation of a Pharmacological Effect [in Russian], Riga (1959).

  2. L. V. Krushinskii, The Formation of Animal Behavior under Normal and Pathological Conditions [in Russian], Moscow (1960).

  3. M. N. Maslova and R. A. Khaunina, in: Evolutionary Neurophysiology and Neurochemistry [in Russian], Leningrad (1967), p. 186.

  4. R. A. Khaunina, Byull. Éksp. Biol. Med., No. 1, 54 (1964).

    Google Scholar 

  5. R. A. Khaunina, Farmakol. Toksikol., No. 4, 399 (1964).

    Google Scholar 

  6. R. A. Khaunina, Farmakol. Toksikol., No. 2, 202 (1968).

    Google Scholar 

  7. R. A. Khaunina, in: Problems in the Pharmacology of Neurotropic Agents (Abstracts of Proceedings of a Conference) [in Russian], Riga (1971), p. 211.

  8. R. A. Khaunina and I. B. Prakh'e, Patol. Fiziol., No. 6, 72 (1966).

    Google Scholar 

  9. S. P. Bessman, in: The Neurochemistry of Nucleotides and Amino Acids (Symposium), edited by R. O. Brady and D. B. Tower, New York (1960), p. 157.

  10. E. Chojnacka-Wojcik et al., Arch. Immunol. Ther. Exp.,23, 733 (1975).

    Google Scholar 

  11. J. E. Hawkins and L. H. Sarett, Clin. Chim. Acta,2, 481 (1957).

    Google Scholar 

  12. J. E. Lightowler and J. A. R. MacLean, Arch. Int. Pharmacodyn.,145, 233 (1963).

    Google Scholar 

  13. E. W. Maynert and H. K. Kaja, J. Pharmacol. Exp. Ther.,137, 114 (1962).

    Google Scholar 

  14. D. P. Purpura et al., J. Neurochem.,6, 238 (1959).

    Google Scholar 

  15. J. Sieroslawska, Diss. Pharm. Pharmacol.,16, 465 (1964).

    Google Scholar 

  16. J. Sieroslawska, Arch. Immunol. Ther. Exp.,13, 70 (1965).

    Google Scholar 

  17. D. B. Tower, in: The Neurochemistry of Nucleotides and Amino Acids (ed. by R. O. Brady and D. B. Tower), New York (1960), p. 154.

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khaunina, R.A. Neurotropic activity of phenylpyrrolidone-2 isomers. Bull Exp Biol Med 85, 317–320 (1978). https://doi.org/10.1007/BF00801346

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00801346

Key Words

Navigation